Close Menu

NEW YORK — Xiamen Wiz Biotech has received CE marking for its SARS-CoV-2 rapid antibody-detection kit.

The qualitative membrane-based immunoassay is designed to detect immunoglobulin G and M antibodies against the virus in whole blood, serum, and plasma, according to the Xiamen, China-based company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.